Neurofilament light chain serum levels as a possible paclitaxel-induced peripheral neurotoxicity biomarker: Pilot and feasibility study

被引：0
|
作者：
Alberti, Paola [1 ]
Cicchiello, Federica [2 ]
Riva, Francesca [2 ]
Cazzaniga, Marina [1 ,2 ]
机构：
[1] Univ Milano Bicocca, Monza, Italy
[2] San Gerardo Hosp, Med Oncol Unit, Monza, Italy
来源：
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM | 2020年 / 25卷 / 04期
关键词：
Taxane-induced peripheral neurotoxicity; NfL serum levels; surrogate biomarkers;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
133
引用
收藏
页码：481 / 482
页数：2
相关论文
共 50 条
  • [41] Serum and CSF neurofilament light chain as possible biomarker in anti-neuropil antibody-associated encephalitis
    Mariotto, S.
    Zuliani, L.
    Zoccarato, M.
    Gastaldi, M.
    Franciotta, D.
    Cantalupo, G.
    Piardi, F.
    Polo, A.
    Alberti, D.
    Zanusso, G.
    Sechi, E.
    Monaco, S.
    Ferrari, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 555 - 555
  • [42] Serum tryptase levels in patients with psoriasis: a pilot study for a possible useful biomarker
    Paolino, G.
    Di Nicola, M. R.
    Currado, M.
    Brianti, P.
    Mercuri, S. R.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2022, 47 (01) : 178 - 179
  • [43] Serum Neurofilament Light Chain Levels as a Biomarker of Disease Activity, Progression and Treatment Response in Patients with Multiple Sclerosis
    Fabis-Pedrini, Marzena
    Kaskow, Belinda
    Trend, Stephanie
    Carroll, William
    Walters, Sue
    Maceski, Aleksandra
    Kuhle, Jens
    Kermode, Allan
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 (07) : NP2 - NP2
  • [44] Value of serum neurofilament light chain levels as a biomarker of suboptimal treatment response in MS clinical practice.
    Yaldizli, O.
    Barro, C.
    Michalak, Z.
    Vehoff, J.
    Lascano, A. M.
    Disanto, G.
    Salmen, A.
    Derfuss, T.
    Granziera, C.
    Achtnichts, L.
    Findling, O.
    Nedeltchev, K.
    Kamm, C. P.
    Pot, C.
    Schluep, M.
    Du Pasquier, R.
    von Wyl, V.
    Wuerfel, J.
    Vallejo, V.
    Chan, A.
    Zecca, C.
    Gobbi, C.
    Lalive, P. H.
    Mueller, S.
    Kappos, L.
    Benkert, P.
    Kuhle, J.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 97 - 98
  • [45] Serum neurofilament light chain as a diagnostic and prognostic biomarker in multiple system atrophy: a prospective cohort study
    Liu, Min
    Cai, Yanning
    Pan, Jing
    Wang, Ting
    Li, Yuan
    Yu, Qian
    Mao, Wei
    Chan, Piu
    JOURNAL OF NEUROLOGY, 2025, 272 (01)
  • [46] Preliminary study of neurofilament light chain as a biomarker for hypoxia-induced neuronal injury in dogs
    Yun, Taesik
    Chae, Yeon
    Koo, Yoonhoi
    Lee, Dohee
    Kim, Hakhyun
    Yang, Mhan-Pyo
    Kang, Byeong-Teck
    FRONTIERS IN VETERINARY SCIENCE, 2023, 10
  • [47] Serum neurofilament light chain as a potential biomarker in restless legs syndrome: a cross-sectional study
    Yetis, Aysu
    Celikbilek, Asuman
    Ilanbey, Bilal
    Konar, Naime Meric
    Duran, Selcen
    NEUROLOGICAL RESEARCH, 2025,
  • [48] Exploring the correlation between paediatric narcolepsy and serum neurofilament light chain levels: An exploratory study
    Li, Weifeng
    Sun, Meijun
    Chen, Chen
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2024, 52 : 82 - 85
  • [49] Serum neurofilament light chain levels in migraine patients: a monocentric case–control study in China
    Jie Fang
    Jielong Wu
    Tengkun Zhang
    Xiaodong Yuan
    Jiedong Zhao
    Liangcheng Zheng
    Ganji Hong
    Lu Yu
    Qing Lin
    Xingkai An
    Chuya Jing
    Qiuhong Zhang
    Chen Wang
    Zhanxiang Wang
    Qilin Ma
    The Journal of Headache and Pain, 24
  • [50] Serum Neurofilament Light Chain Levels as a Biomarker of Disease Activity and Treatment Response in Patients with Progressive and Relapsing Multiple Sclerosis
    Pedrini, Marzena
    Kaskow, Belinda
    Trend, Stephanie
    Carroll, William
    Walters, Susan
    Maceski, Aleksandra
    Kuhle, Jens
    Kermode, Allan
    NEUROLOGY, 2023, 100 (17)
12345